Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing polychondritis.

J F Molina1, L R Espinoza

  • 1Unidad de Reumatología, Hospital Pable Tobón Uribe, Medellin, Colombia.

Bailliere'S Best Practice & Research. Clinical Rheumatology
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.

Arthritis and rheumatism·2010
Same author

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal.

Lupus·2009
Same author

Gout in latin america.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Gouty arthritis mimicking rheumatoid arthritis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

A clinical profile of reactive arthritis in a peruvian series: a pilot study.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Fibromyalgia syndrome in young children: onset at age 10 years and younger.

Clinical and experimental rheumatology·2007

Relapsing polychondritis is a rare autoimmune disease causing cartilage and connective tissue inflammation. Treatment often involves corticosteroids and other anti-inflammatory drugs for symptom management.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Relapsing polychondritis (RP) is a rare systemic inflammatory disorder.
  • It is characterized by recurrent inflammation and destruction of cartilaginous structures and connective tissue.
  • While an autoimmune basis is increasingly supported, the etiology remains unknown.

Purpose of the Study:

  • To summarize the current understanding of relapsing polychondritis.
  • To highlight key clinical features and associated disorders.
  • To discuss current treatment strategies.

Main Methods:

  • Literature review of existing studies on relapsing polychondritis.
  • Analysis of clinical presentations and epidemiological data.
  • Review of therapeutic approaches.

Related Experiment Videos

Main Results:

  • RP affects individuals of all races, genders, and ages, predominantly between 40-60 years.
  • Common manifestations include chondritis of the ear, nose, and respiratory tract, with ocular and audiovestibular involvement.
  • Associated conditions include rheumatic and hematologic disorders, particularly vasculitic syndromes.

Conclusions:

  • Relapsing polychondritis is a complex inflammatory condition with a suspected autoimmune origin.
  • Early recognition of clinical features and associated disorders is crucial for management.
  • Corticosteroids remain the primary treatment, with other anti-inflammatory agents used for refractory cases or steroid-sparing.